Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2026-06-12 16:16:25 ET · period of report 2026-06-10 · accession 0001104659-26-073476 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 16:16 | 2026-06-10 | OBIO | Taylor Andrew Lawrence | CFO | F - Tax | $4.02 | -36.4K | 593.1K | -6% | -$146.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2026-06-10 | F | D | 36,352 | $4.02 | 593,065 | D | — | — | (F1) Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations. |